Clene (CLNN) Competitors $3.66 -0.08 (-2.14%) Closing price 07/24/2025 03:59 PM EasternExtended Trading$3.78 +0.13 (+3.42%) As of 08:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLNN vs. FTLF, TARA, KRRO, SKYE, ACTU, ALTS, ATOS, CLLS, BHST, and TNYAShould you be buying Clene stock or one of its competitors? The main competitors of Clene include FitLife Brands (FTLF), Protara Therapeutics (TARA), Korro Bio (KRRO), Skye Bioscience (SKYE), Actuate Therapeutics (ACTU), ALT5 Sigma (ALTS), Atossa Genetics (ATOS), Cellectis (CLLS), BioHarvest Sciences (BHST), and Tenaya Therapeutics (TNYA). These companies are all part of the "pharmaceutical products" industry. Clene vs. Its Competitors FitLife Brands Protara Therapeutics Korro Bio Skye Bioscience Actuate Therapeutics ALT5 Sigma Atossa Genetics Cellectis BioHarvest Sciences Tenaya Therapeutics Clene (NASDAQ:CLNN) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Which has more volatility & risk, CLNN or FTLF? Clene has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Is CLNN or FTLF more profitable? FitLife Brands has a net margin of 13.85% compared to Clene's net margin of -8,306.00%. FitLife Brands' return on equity of 25.59% beat Clene's return on equity.Company Net Margins Return on Equity Return on Assets Clene-8,306.00% N/A -105.11% FitLife Brands 13.85%25.59%15.26% Which has stronger earnings & valuation, CLNN or FTLF? FitLife Brands has higher revenue and earnings than Clene. Clene is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClene$340K89.02-$39.40M-$4.04-0.91FitLife Brands$64.47M1.93$8.98M$0.8415.80 Does the media prefer CLNN or FTLF? In the previous week, FitLife Brands had 1 more articles in the media than Clene. MarketBeat recorded 4 mentions for FitLife Brands and 3 mentions for Clene. FitLife Brands' average media sentiment score of 1.05 beat Clene's score of 0.63 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clene 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CLNN or FTLF? Clene currently has a consensus target price of $40.00, suggesting a potential upside of 992.90%. FitLife Brands has a consensus target price of $20.50, suggesting a potential upside of 54.48%. Given Clene's higher probable upside, equities research analysts plainly believe Clene is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clene 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do insiders & institutionals hold more shares of CLNN or FTLF? 23.3% of Clene shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 35.3% of Clene shares are owned by company insiders. Comparatively, 61.4% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryFitLife Brands beats Clene on 12 of the 16 factors compared between the two stocks. Get Clene News Delivered to You Automatically Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLNN vs. The Competition Export to ExcelMetricCleneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.92M$3.05B$5.72B$9.47BDividend YieldN/A2.40%4.60%3.99%P/E Ratio-0.9120.8627.9419.95Price / Sales89.02317.05452.94100.82Price / CashN/A43.2336.5558.97Price / Book-3.458.308.645.90Net Income-$39.40M-$55.19M$3.24B$258.42M7 Day Performance-4.19%5.81%3.69%2.11%1 Month Performance-10.73%17.73%10.33%12.44%1 Year Performance-17.94%4.67%34.30%19.55% Clene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLNNClene3.4454 of 5 stars$3.66-2.1%$40.00+992.9%-19.2%$30.92M$340K-0.91100FTLFFitLife Brands4.277 of 5 stars$13.09+0.5%$20.50+56.6%-20.0%$122.92M$64.47M15.5820News CoveragePositive NewsTARAProtara Therapeutics2.0779 of 5 stars$3.16+3.6%$20.50+548.7%+44.0%$121.91MN/A-1.8430Positive NewsKRROKorro Bio1.8772 of 5 stars$12.97+2.0%$102.43+689.7%-67.0%$121.79M$2.27M-1.3770News CoverageAnalyst ForecastSKYESkye Bioscience1.8633 of 5 stars$3.93-1.3%$16.60+322.4%-32.7%$121.73MN/A-4.7911News CoverageACTUActuate Therapeutics2.275 of 5 stars$6.20+1.0%$20.50+230.6%N/A$121.64MN/A0.0010ALTSALT5 Sigma0.1425 of 5 stars$6.96-11.7%N/A+262.2%$121.45M$12.53M0.00170ATOSAtossa Genetics3.0813 of 5 stars$0.94-0.2%$6.17+558.4%-38.4%$120.98MN/A-4.468News CoveragePositive NewsCLLSCellectis2.8161 of 5 stars$2.15+35.2%$4.00+86.0%-2.0%$119.50M$49.22M-2.50290Positive NewsHigh Trading VolumeBHSTBioHarvest SciencesN/A$7.05-1.8%$13.67+93.9%N/A$115.80M$27.70M-14.10N/ANews CoverageTNYATenaya Therapeutics3.8444 of 5 stars$0.71+4.1%$6.25+778.5%-77.2%$115.72MN/A-0.61110Positive News Related Companies and Tools Related Companies FTLF Competitors TARA Competitors KRRO Competitors SKYE Competitors ACTU Competitors ALTS Competitors ATOS Competitors CLLS Competitors BHST Competitors TNYA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLNN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
